Computed Tomography (CECT) is the most common modality of imaging a renal mass. While metrics including pixel enhancement have been described for differentiation of various types of tumors, we describe an additional technique of texture analysis.
INTRODUCTION AND OBJECTIVES: Radiofrequency ablation (RFA) has become an acceptable nephron-sparing treatment for small renal masses. It is sometimes considered for patients with high likelihood of repeat interventions, such as those with multifocal lesions from hereditary syndromes. Available long-term renal functional outcomes for patients with multiple lesions are limited predominantly to the surgical approach, and little is known about the effect of multiple tumor ablations in single procedure. Our aim is to compare the longeterm renal functional changes for patients who had a single lesion vs. of multiple lesions treated with RFA.
METHODS: Our institution review board approved study registry was queried for patients treated using RFA with single or multiple ablation zones. This series was limited to first ablative procedures, and follow-up was censored to time of next surgical or interventional procedures. Clinical features and renal functional outcomes as measured by change in eGFR and rate of eGFR<45 were compared between groups. Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 THE JOURNAL OF UROLOGY â e225 RESULTS: Overall, 63 patients met inclusion criteria and had 89.7 median months of follow-up. Of these 46 (73.0%) underwent single vs 17 (27.0%) underwent multiple tumor ablation during a single procedure. Patients who had multiple tumors ablated were had greater total tumor volume (median volume 14.5cm3 vs 9.2cm3, p < 0.001), were more likely to have been treated laparoscopically (47.1% vs 13.0%), but had similar age, gender distribution, BMI, baseline eGFR, overall survival, and length of follow-up. The rate of hereditary syndrome diagnosis between the multiple vs single ablation groups were significantly different (p<0.001): Von Hippel-Lindau (76.4% vs 84.7%), familial oncocytoma (5.9% vs 2.2%), hereditary papillary renal cancer (11.8% vs 2.2%), Birt-Hogg-Dube (11.8% vs 2.2). Multiple and single tumor ablations were associated with a similar median change in eGFR (mL/ min/1.73 m 2 ) at 1 year (-6.60 vs. -1.65, p¼0.306) , and at last follow-up (-22.0 vs. 18.9 p¼0.676), as well as freedom from GFR<45 at last follow-up (5.9% vs. 4.3%, p¼0.618).
CONCLUSIONS: In this series, multiple and single tumor ablations were associated with similar renal functional outcomes. These data suggest that multiple tumors can be safely ablated in patients with multifocal disease. 
MP18-15 NEW CLASSIFICATION OF HYDRONEPHROSIS ON FDG-PET/CT PREDICTS POSTOPERATIVE RENAL FUNCTION AND PATHOLOGICAL OUTCOMES IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA
Seiji Asai*, Ousuke Arai, Terutaka Noda, Tetsuya Fukumoto, Noriyoshi Miura, Yutaka Yanagihara, Yuki Miyauchi, Masao Miyagawa, Tadahiko Kikugawa, Takashi Saika, Toon, Japan INTRODUCTION AND OBJECTIVES: Fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is useful for detecting of primary lesion and metastasis in patients with upper urinary tract urothelial carcinoma (UTUC). However, there is no study about ipsilateral hydronephrosis on FDG-PET/CT in patients with UTUC. We aimed to evaluate the value of our classification of hydronephrosis on FDG-PET/CT to predict postoperative renal function and pathological outcomes.
METHODS: We retrospectively reviewed patients treated with nephroureterectomy (NU) for UTUC at our institution from 2010 to 2016. Among them, 71 patients were examined by FDG-PET/CT before NU. Patients treated with ureteral stent or nephrostomy at the time of FDG-PET/CT scan were excluded, leaving 64 patients for analysis. We classified the hydronephrosis on FDG-PET/CT based on the renal FDG excretion as follows: type0 : no hydronephrosis; type1 : hydronephrosis with FDG accumulation; type2 : hydronephrosis without FDG accumulation. Estimated glomerular filtration rate (eGFR [ml/min/1.73m 2 ]) was calculated before the treatment and at early (within 1 month) and late (3-6 months) time points after NU. The change of eGFR was calculated at early time point after NU compared to pretreatment eGFR. The renal dysfunction event, defined as new-onset stage3 chronic kidney disease (CKD) or worsening of CKD stage, was evaluated at late time point after NU compared to pretreatment eGFR. SPSS was used for statistical analysis.
RESULTS: The patients of type 0, 1, 2 were 30 (47%), 18 (28%) and 16 (25%), respectively. The median change of eGFR in type 0, 1, 2 was -23.9, -19.4 and 2.4 ml/min/1.73m 2 , respectively. The renal dysfunction event rate was the lowest in type2 group (86, 63 vs 19%) . On multivariate analysis, classification of hydronephrosis and preoperative eGFR were associated with renal dysfunction event (p<0.05). Furthermore, type2 hydronephrosis was significantly associated with pahological grade3, LVI+, !pT2 (muscle invasive cancer) and pN+ (p<0.05). On multivariate analysis, type2 hydronephrosis was associated with muscle invasive UTUC (p<0.05).
CONCLUSIONS: We classified the hydronephrosis based on renal FDG excretion. The classification of pretreatment hydronephrosis on FDG-PET/CT is simple and useful for predicting postoperative renal function and worse pathological outcomes in patients with UTUC.
Source of Funding: none

MP18-16 THE IMPORTANCE OF UROLOGIST ESTIMATION OF STONE BURDEN: RESULTS FROM THE REGISTRY FOR STONES OF THE KIDNEY AND URETER (RESKUÔ)
David T. Tzou*, Dylan Isaacson, Manint Usawachintachit, Kazumi Taguchi, Benjamin A. Sherer, Marshall L. Stoller, Thomas Chi, San Francisco, CA
INTRODUCTION AND OBJECTIVES: A discrepancy often exists between urologists
0 and radiologists 0 estimation of a patient 0 s true stone burden. Current AUA guidelines recommend treatment based on stone size thresholds and therefore accurate stone measurements are critical in directing patients to the most appropriate surgery. With an increasing trend towards determining quality of care based on the amount of stone removed, accurate stone burden estimation is essential to defining operative success. This study aimed to compare the number, size, and location of stones recorded by urologists and radiologists, and determine what discrepancies exist and how these differences could impact stone management.
METHODS: From October 2015 to August 2016, 371 new stone patients at University of California, San Francisco were prospectively enrolled into the Registry for Stones of the Kidney and Ureter (ReSKU TM ). Treating urologists personally reviewed all computed tomography (CT) imaging, recording stone number, location, and total stone burden. Stone burden was based on the largest aggregate linear dimension from axial and coronal views. A blinded, retrospective review of the corresponding radiologic reports for these patients was then performed, comparing how often these key attributes were mentioned. A report was categorized as unclear for each characteristic when it failed to specifically mention the number, location or total stone burden.
RESULTS: A total of 219 patients had both CT images and a report available for review. With regard to stone number, 57/219 (26%) of reports were considered unclear. Radiologists reported significantly smaller stone burden than urologists for both single stones (8.8 AE 9.2 mm vs 10.7 AE 11.8 mm, p <0.001) and multiple stones (12.7 AE 10.0 mm vs 21.3 AE 20.3 mm, p <0.001, paired-sample t test). Of 300 stonecontaining renal units, 90 (30%) had a radiology description that was either unclear or based on size discrepancy could have resulted in a potential change in surgical management (Table 2) .
CONCLUSIONS: There is a statistically significant difference in the estimation of stone size between urologist and radiologist interpretation of CT scans. To optimize appropriate surgical selection and allow for quality outcomes measurements, urologists should perform their own imaging interpretation.
